Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CogDx appears to be a digital health company focused on software-based mental health and cognitive assessment delivered through interactive video game experiences. Publicly available materials indicate that its product is positioned as a mental health assessment tool rather than a therapeutics developer, with emphasis on evaluating brain or cognitive disorders through user-completed tasks. Trademark records describe CogDx software as being used to diagnose brain disorders via cognitive evaluation tasks, and the company website presents the offering as mental health assessment by playing video games. Based on the available evidence, CogDx is best characterized as a healthcare software/platform company rather than a traditional biotech or pharmaceutical developer. There is no clear evidence of a drug pipeline, therapeutic assets, or clinical-stage pharmaceutical programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CogDx.